عنوان

Antithrombotic drug therapy in cardiovascular disease /

شابک

1603272356

شابک

9781603272353

شابک اشتباه

1603272348

شابک اشتباه

9781603272346

شماره

b769149

عنوان اصلي

Antithrombotic drug therapy in cardiovascular disease /

نام عام مواد

[Book]

نام نخستين پديدآور

edited by Arman T. Askari, A. Michael Lincoff.

محل نشرو پخش و غیره

New York :

نام ناشر، پخش کننده و غيره

Humana Press,

تاریخ نشرو بخش و غیره

©2010.

نام خاص و کميت اثر

1 online resource (xiii, 475 pages) :

ساير جزييات

illustrations (some color)

عنوان فروست

Contemporary cardiology (Totowa, N.J. : Unnumbered)

متن يادداشت

Includes bibliographical references and index.

متن يادداشت

Basic principles -- Platelets in arterial thrombosis -- Role of coagulation in arterial and venous thrombosis -- Link between inflammation and thrombosis -- Genetics of thrombosis -- Antithrombotic therapy for stable coronary atherosclerotic disease -- Aspirin in primary and secondary prevention of cardiovascular disease -- Thienopyridines in stable coronary disease -- Antithrombotic therapy for NSTE ACS -- Antiplatelet therapies in unstable angina and non-ST segment elevation myocardial infarction -- Unfractionated heparin and enoxaparin for the management of non-ST-segment elevation acute coronary syndromes -- Direct thrombin inhibitors in acute coronary syndromes -- Synthetic factors Xa inhibition in acute coronary syndromes -- Antithrombotic therapy for STEMI -- Antiplatelet therapies: aspirin, clopidogrel and thienopyridines, and glycoprotein IIb/IIIa inhibitors for the management of ST-segment elevation myocardial infarction -- Antithrombin therapy for acute ST-segment elevation myocardial infarction -- Fibrinolysis and facilitated PCI -- Antithrombotic therapy in interventional cardiology -- Antithrombotic therapy in percutaneous coronary intervention -- Antithrombotic therapy in carotid and peripheral intervention -- Monitoring of antithrombotic therapies in interventional cardiology -- Antithrombotic therapy in venous thromboembolism -- Venous thromboembolism -- Fibrinolysis for pulmonary embolism -- Duration of anticoagulant therapy after venous thromboembolism -- Clinical consideration -- Antithrombotic therapy for atrial fibrillation and cardioversion -- Antithrombotic therapy for valvular heart disease -- Antithrombotic therapy in heart failure and cardiomyopathy -- Heparin-induced thrombocytopenia -- Resistance to antiplatelet drugs.

بدون عنوان

0

متن يادداشت

Substantial morbidity and mortality remains associated with thrombotic events has stimulated the rapid expansion of the available armamentarium to combat pathologic thrombosis. Pathologic thrombosis plays an essential role in the pathogenesis of acute coronary syndromes (ACS), ischemic complications of percutaneous coronary intervention (PCI), venous thromboembolic disease, and embolic complications of arrhythmias and various cardiomyopathies. Written by experts in the field, Antithrombotic Drug Therapy in Cardiovascular Disease carefully examines individual and various combinations of the available antithrombotic regimens including fibrinolytic agents, antiplatelet therapies (aspirin, thieneopyridines, glycoprotein IIb/IIIa inhibitors), and anticogulant therapies (unfractionated heparin, low-molecular-weight heparins, direct thrombin inhibitors, and synthetic factor X inhibitors), non-ST-segment elevation (NSTE) ACS and ST-segment elevation myocardial infarction (STEMI). A detailed overview, Antithrombotic Drug Therapy in Cardiovascular Disease presents the evidence demonstrating the efficacy of available antithrombotic therapies in specific disease states such as atrial fibrillation, cardiomyopathy, valvular heart disease, and heparin-induced thrombocytopenia (HIT).

منبع سفارش / آدرس اشتراک

Springer

شماره انبار

978-1-60327-234-6

عنوان

Antithrombotic drug therapy in cardiovascular disease.

شماره استاندارد بين المللي کتاب و موسيقي

1603272348

موضوع مستند نشده

Cardiovascular system-- Diseases-- Chemotherapy.

موضوع مستند نشده

Fibrinolytic agents.

موضوع مستند نشده

Cardiovascular Diseases-- drug therapy.

موضوع مستند نشده

Fibrinolytic Agents-- therapeutic use.

موضوع مستند نشده

Thrombolytic Therapy.

موضوع مستند نشده

Thrombosis-- drug therapy.

موضوع مستند نشده

Cardiovascular system-- Diseases-- Chemotherapy.

موضوع مستند نشده

Fibrinolytic agents.

موضوع مستند نشده

Médecine.

شماره

ويراست

شماره رده

شماره رده

نشانه اثر

مستند نام اشخاص تاييد نشده

Askari, Arman T.

مستند نام اشخاص تاييد نشده

Lincoff, A. Michael.

تاريخ عمليات

20201206150619.0

قواعد فهرست نويسي ( بخش توصيفي )

pn

نام الکترونيکي

نوع ماده

[Book]

تكميل شده

Y